Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-09-29

FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for NEXTERONE (amiodarone hydrochloride) from Baxter Healthcare Company, resulting in changes to the drug's labeling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEXTERONE (AMIODARONE HYDROCHLORIDE)

Snippet

SUPPL AP for NEXTERONE (AMIODARONE HYDROCHLORIDE)